hydroxyurea has been researched along with Skin Diseases in 35 studies
Skin Diseases: Diseases involving the DERMIS or EPIDERMIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Between 1980 and 1991, 96 patients with documented polycythemia vera were treated by hydroxyurea or pipobroman, according to a protocol including randomization, and maintenance therapy." | 9.07 | [Treatment of polycythemia vera with hydroxyurea or pipobroman. Efficacy and toxicity analysed from a protocol of 96 patients under 65 years of age. Le Groupe d'Etude des Polyglobulies]. ( Najean, Y, 1992) |
| "Treatment with hydroxyurea was followed by a marked reduction in spleen size, a decrease in white cell count and healing of the skin lesions." | 5.26 | Chronic granulocytic leukemia cutis treated with hydroxyurea. Report of a case. ( Atamer, MA; Friedhoff, FW; Thelmo, WL, 1978) |
| "Between 1980 and 1991, 96 patients with documented polycythemia vera were treated by hydroxyurea or pipobroman, according to a protocol including randomization, and maintenance therapy." | 5.07 | [Treatment of polycythemia vera with hydroxyurea or pipobroman. Efficacy and toxicity analysed from a protocol of 96 patients under 65 years of age. Le Groupe d'Etude des Polyglobulies]. ( Najean, Y, 1992) |
| "Our rate of hydroxyurea-induced leg ulcers (29%) is higher than that reported for patients with myeloproliferative syndromes (9%)." | 3.71 | Cutaneous adverse reactions to hydroxyurea in patients with sickle cell disease. ( Aractingi, S; Chaine, B; Girot, R; Neonato, MG, 2001) |
| " However, these agents also place patients at increased risk for drug-related cutaneous adverse events." | 2.66 | Drug-Related Cutaneous Adverse Events in Philadelphia Chromosome-Negative Myeloproliferative Neoplasms: A Literature Review. ( Guglielmelli, P; Malato, A; Palumbo, GA; Pugliese, N; Rossi, E, 2020) |
| " On long-term use (2-15 years) of 1500-2000 mg a day, there is a 9% risk of developing ulcers." | 1.56 | [An 84-year-old man with an ulcer on his ankle]. ( Houwing, RH; Sanders-Koers, R; van Berkum-Zandkamp, N, 2020) |
| "The hypereosinophilic syndrome is a multi-organ disease characterized by large counts of eosinophils in peripheral blood observed during at least six months without any evidence for other known causes of eosinophilia." | 1.33 | [The hypereosinophilic syndrome: case report]. ( Grzybowski, G; Mikołajczyk, K; Samborski, W; Walkowiak, B; Zaba, R, 2006) |
| "Hydroxyurea is a treatment of myeloproliferative syndromes." | 1.31 | [Secondary cutaneous effects of hydroxyurea: prospective study of 26 patients from a dermatologic consultation]. ( Bernard, P; Leborgne, G; Potron, G; Salmon-Ehr, V; Vilque, JP, 2000) |
| "Nonspecific cutaneous xanthomas have occasionally been reported with a variety of leukemias, mostly in the pediatric literature, but the first report (to our knowledge) of acute myelomonocytic leukemia presenting with specific cutaneous xanthomatous lesions appeared in 1982." | 1.27 | Cutaneous xanthomas associated with chronic myelomonocytic leukemia. ( Adler, KR; Rothenberg, J; Vail, JT, 1985) |
| "Treatment with hydroxyurea was followed by a marked reduction in spleen size, a decrease in white cell count and healing of the skin lesions." | 1.26 | Chronic granulocytic leukemia cutis treated with hydroxyurea. Report of a case. ( Atamer, MA; Friedhoff, FW; Thelmo, WL, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (31.43) | 18.7374 |
| 1990's | 5 (14.29) | 18.2507 |
| 2000's | 11 (31.43) | 29.6817 |
| 2010's | 4 (11.43) | 24.3611 |
| 2020's | 4 (11.43) | 2.80 |
| Authors | Studies |
|---|---|
| van Berkum-Zandkamp, N | 1 |
| Houwing, RH | 1 |
| Sanders-Koers, R | 1 |
| Malato, A | 1 |
| Rossi, E | 1 |
| Palumbo, GA | 1 |
| Guglielmelli, P | 1 |
| Pugliese, N | 1 |
| Stegelmann, F | 2 |
| Wille, K | 2 |
| Busen, H | 1 |
| Fuchs, C | 1 |
| Schauer, S | 1 |
| Sadjadian, P | 2 |
| Becker, T | 1 |
| Kolatzki, V | 1 |
| Döhner, H | 1 |
| Stadler, R | 1 |
| Döhner, K | 2 |
| Griesshammer, M | 2 |
| Cozzani, E | 1 |
| Iurlo, A | 1 |
| Merlo, G | 1 |
| Cattaneo, D | 1 |
| Burlando, M | 1 |
| Pierri, I | 1 |
| Gugliotta, L | 1 |
| Parodi, A | 1 |
| Grandi, V | 1 |
| Delfino, C | 1 |
| Pimpinelli, N | 1 |
| Dem, A | 1 |
| Diallo, M | 1 |
| Gaye Fall, MC | 1 |
| Dieng, MM | 1 |
| Gaye, M | 1 |
| Touré, P | 1 |
| Latagliata, R | 1 |
| Spadea, A | 1 |
| Cedrone, M | 1 |
| Di Giandomenico, J | 1 |
| De Muro, M | 1 |
| Villivà, N | 1 |
| Breccia, M | 1 |
| Anaclerico, B | 1 |
| Porrini, R | 1 |
| Spirito, F | 1 |
| Rago, A | 1 |
| Avvisati, G | 1 |
| Alimena, G | 1 |
| Montanaro, M | 1 |
| Andriani, A | 1 |
| Bartolucci, P | 1 |
| Galactéros, F | 1 |
| Belgi, G | 1 |
| Friedmann, PS | 1 |
| Bravo Blanco, AM | 1 |
| Moral, JL | 1 |
| Tembrás, S | 1 |
| Gómez, R | 1 |
| Ulibarrena, C | 1 |
| Obdulia Vazquez, M | 1 |
| Sanchez-Palacios, C | 1 |
| Guitart, J | 1 |
| Mikołajczyk, K | 1 |
| Zaba, R | 1 |
| Walkowiak, B | 1 |
| Grzybowski, G | 1 |
| Samborski, W | 1 |
| Pfeifle, CE | 1 |
| Howell, SB | 1 |
| Spry, CJ | 1 |
| van Genderen, PJ | 1 |
| Michiels, JJ | 1 |
| van der Poel-van de Luytgaarde, SC | 1 |
| van Vliet, HH | 1 |
| Koike, M | 1 |
| Ishiyama, T | 1 |
| Salmon-Ehr, V | 2 |
| Grosieux, C | 1 |
| Potron, G | 2 |
| Kalis, B | 1 |
| Leborgne, G | 1 |
| Vilque, JP | 1 |
| Bernard, P | 1 |
| Young, HS | 1 |
| Khan, AS | 1 |
| Kendra, JR | 1 |
| Coulson, IH | 1 |
| Laughon, SK | 1 |
| Shinn, LL | 1 |
| Nunley, JR | 1 |
| Chaine, B | 1 |
| Neonato, MG | 1 |
| Girot, R | 1 |
| Aractingi, S | 1 |
| O'branski, EE | 1 |
| Ware, RE | 1 |
| Prose, NS | 1 |
| Kinney, TR | 1 |
| Tanaka, M | 1 |
| Kanamori, H | 1 |
| Yamaji, S | 1 |
| Mishima, A | 1 |
| Yamazaki, E | 1 |
| Taguchi, J | 1 |
| Aoba, M | 1 |
| Fujisawa, S | 1 |
| Mohri, H | 1 |
| Ishigatsubo, Y | 1 |
| McMeekin, TO | 1 |
| Moschella, SL | 1 |
| Friedhoff, FW | 1 |
| Atamer, MA | 1 |
| Thelmo, WL | 1 |
| Najean, Y | 1 |
| Hillyer, MH | 1 |
| Mair, TS | 1 |
| Osterwalder, B | 1 |
| Schmid, L | 1 |
| Jungi, WF | 1 |
| Flury, R | 1 |
| Schmid, U | 1 |
| Staub, P | 1 |
| Senn, HJ | 1 |
| Zaumseil, RP | 1 |
| Taube, KM | 1 |
| Vail, JT | 1 |
| Adler, KR | 1 |
| Rothenberg, J | 1 |
| Dantzig, PI | 1 |
| Lèques, B | 1 |
| Texier, L | 1 |
| Verdaguer, S | 1 |
| Hoffman-Martinot, R | 1 |
| Paulet, C | 1 |
| Moine, M | 1 |
| Richards, GJ | 1 |
| Chambers, RG | 1 |
10 reviews available for hydroxyurea and Skin Diseases
| Article | Year |
|---|---|
Drug-Related Cutaneous Adverse Events in Philadelphia Chromosome-Negative Myeloproliferative Neoplasms: A Literature Review.
Topics: Humans; Hydroxyurea; Interferons; Janus Kinase Inhibitors; Keratosis, Actinic; Myeloproliferative Di | 2020 |
A review of hydroxyurea-related cutaneous adverse events.
Topics: Anemia, Sickle Cell; Antineoplastic Agents; Humans; Hydroxyurea; Myeloproliferative Disorders; Skin | 2021 |
Essential Thrombocythemia: The Dermatologic Point of View.
Topics: Antineoplastic Agents; Humans; Hydroxyurea; Interferon-alpha; Quinazolines; Skin Diseases; Thrombocy | 2015 |
Clinical management of adult sickle-cell disease.
Topics: Anemia, Sickle Cell; Antisickling Agents; Humans; Hydroxyurea; Hypertension, Pulmonary; Kidney Disea | 2012 |
Traditional therapies: glucocorticoids, azathioprine, methotrexate, hydroxyurea.
Topics: Azathioprine; Dermatologic Agents; Glucocorticoids; Humans; Hydroxyurea; Immunosuppressive Agents; M | 2002 |
Hydroxyurea-associated squamous dysplasia.
Topics: Aged; Carcinoma, Squamous Cell; Humans; Hydroxyurea; Keratosis; Male; Precancerous Conditions; Skin | 2004 |
The hypereosinophilic syndrome: clinical features, laboratory findings and treatment.
Topics: Anticoagulants; Bone Marrow; Central Nervous System Diseases; Endomyocardial Fibrosis; Eosinophilia; | 1982 |
[Hypereosinophilic syndrome].
Topics: Adult; Aged; Cardiovascular Diseases; Eosinophilia; Female; Humans; Hydroxyurea; Leukemia, Eosinophi | 1993 |
Iatrogenic complications of dermatologic therapy. Primum non nocere.
Topics: Adrenal Cortex Hormones; Azathioprine; Cryosurgery; Cyclophosphamide; Electrosurgery; Erythromycin; | 1979 |
Immunosuppressive and cytotoxic drugs in dermatology.
Topics: Animals; Antineoplastic Agents; Azathioprine; Azauridine; Bleomycin; Chlorambucil; Cyclophosphamide; | 1974 |
1 trial available for hydroxyurea and Skin Diseases
| Article | Year |
|---|---|
[Treatment of polycythemia vera with hydroxyurea or pipobroman. Efficacy and toxicity analysed from a protocol of 96 patients under 65 years of age. Le Groupe d'Etude des Polyglobulies].
Topics: Digestive System Diseases; Female; Follow-Up Studies; Humans; Hydroxyurea; Male; Middle Aged; Pipobr | 1992 |
24 other studies available for hydroxyurea and Skin Diseases
| Article | Year |
|---|---|
[An 84-year-old man with an ulcer on his ankle].
Topics: Aged, 80 and over; Ankle; Antineoplastic Agents; Hematologic Neoplasms; Humans; Hydroxyurea; Long Te | 2020 |
Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Female; Follow-Up Studies; Fusion Proteins, b | 2021 |
Ingenol mebutate in the treatment of 'Hydroxyurea-induced Squamous Dysplasia': a single centre experience.
Topics: Aged; Diterpenes; Female; Humans; Hydroxyurea; Male; Middle Aged; Skin; Skin Diseases | 2016 |
[Cutaneous complications of long-term hydroxyurea therapy].
Topics: Adult; Alopecia; Antineoplastic Agents; Atrophy; Female; Hand; Humans; Hydroxyurea; Leukemia, Myelog | 2008 |
Symptomatic mucocutaneous toxicity of hydroxyurea in Philadelphia chromosome-negative myeloproliferative neoplasms: the Mister Hyde face of a safe drug.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Female; Humans; Hydroxyurea; Male; Middle Age | 2012 |
Hydroxyurea-induced skin ulcerations in patients with chronic myeloproliferative disorders.
Topics: Aged; DNA; Enzyme Inhibitors; Female; Humans; Hydroxyurea; Leg Ulcer; Male; Middle Aged; Myeloprolif | 2003 |
[The hypereosinophilic syndrome: case report].
Topics: Adult; Benzamides; Bone Marrow; Diagnosis, Differential; Eosinophils; Humans; Hydroxyurea; Hypereosi | 2006 |
Phase I trial of cytarabine and hydroxyurea.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Child; Cy | 1983 |
Acquired von Willebrand disease as a cause of recurrent mucocutaneous bleeding in primary thrombocythemia: relationship with platelet count.
Topics: Adult; Bleeding Time; Female; Hemorrhage; Humans; Hydroxyurea; Mucous Membrane; Platelet Count; Skin | 1994 |
Multiple actinic keratosis and skin tumors secondary to hydroxyurea treatment.
Topics: Aged; Antineoplastic Agents; Busulfan; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Humans; Hydr | 1998 |
[Secondary cutaneous effects of hydroxyurea: prospective study of 26 patients from a dermatologic consultation].
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Humans; Hydroxyurea; Leg Ulcer; Myeloproliferative | 2000 |
The cutaneous side-effects of hydroxyurea.
Topics: Aged; Alopecia; Carcinoma, Squamous Cell; Female; Humans; Hydroxyurea; Keratosis; Polycythemia Vera; | 2000 |
Melanonychia and mucocutaneous hyperpigmentation due to hydroxyurea use in an HIV-infected patient.
Topics: Antiviral Agents; Female; HIV Infections; Humans; Hydroxyurea; Hyperpigmentation; Melanosis; Middle | 2000 |
Cutaneous adverse reactions to hydroxyurea in patients with sickle cell disease.
Topics: Adult; Age Factors; Anemia, Sickle Cell; Antisickling Agents; Female; Humans; Hydroxyurea; Leg Ulcer | 2001 |
Skin and nail changes in children with sickle cell anemia receiving hydroxyurea therapy.
Topics: Adolescent; Anemia, Sickle Cell; Antisickling Agents; Child; Female; Humans; Hydroxyurea; Hyperpigme | 2001 |
Subcutaneous extramedullary hematopoiesis in a patient with secondary myelofibrosis following polycythemia vera.
Topics: Aged; Female; Hematopoiesis, Extramedullary; Humans; Hydroxyurea; Megakaryocytes; Myeloid Cells; Pol | 2001 |
Chronic granulocytic leukemia cutis treated with hydroxyurea. Report of a case.
Topics: Female; Humans; Hydroxyurea; Leukemia, Myeloid; Middle Aged; Primary Myelofibrosis; Punctures; Skin | 1978 |
Multisystemic eosinophilic epitheliotropic disease in a horse: attempted treatment with hydroxyurea and dexamethasone.
Topics: Animals; Dexamethasone; Eosinophilia; Epithelium; Female; Gastrointestinal Diseases; Horse Diseases; | 1992 |
[Myeloproliferative syndrome and acute febrile neutrophilic dermatosis (Sweet's syndrome)--a rare association].
Topics: Acute Disease; Adrenal Cortex Hormones; Aged; Fever; Humans; Hydroxyurea; Male; Myeloproliferative D | 1987 |
[Coexistence of psoriasis vulgaris and porphyria cutanea tarda in a patient treated with hydroxycarbamid. Case report].
Topics: Humans; Hydroxyurea; Male; Middle Aged; Porphyrias; Psoriasis; Skin Diseases | 1986 |
Cutaneous xanthomas associated with chronic myelomonocytic leukemia.
Topics: Adult; Female; Humans; Hydroxyurea; Leukemia, Myeloid; Prednisone; Skin Diseases; Xanthomatosis | 1985 |
[A new etiology of inflammatory livedo: thrombocytosis].
Topics: Arteritis; Busulfan; Diagnosis, Differential; Erythromelalgia; Female; Foot Dermatoses; Humans; Hydr | 1969 |
Anaflex and noxyflex: low-toxicity antiseptics.
Topics: Anti-Infective Agents, Local; Female; Formaldehyde; Humans; Hydroxyurea; Skin Diseases; Thiourea; Ur | 1970 |
Hydroxyurea: a radiosensitizer in the treatment of neoplasms of the head and neck.
Topics: Adult; Age Factors; Aged; Female; Gastrointestinal Diseases; Head; Head and Neck Neoplasms; Hematolo | 1969 |